{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T04:21:04Z","timestamp":1751516464350,"version":"3.41.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,3,19]],"date-time":"2018-03-19T00:00:00Z","timestamp":1521417600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s00467-018-3935-1","type":"journal-article","created":{"date-parts":[[2018,3,19]],"date-time":"2018-03-19T02:57:23Z","timestamp":1521428243000},"page":"413-422","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Use of calcimimetics in children with normal kidney function"],"prefix":"10.1007","volume":"34","author":[{"given":"Judith Sebestyen","family":"VanSickle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarak","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uri S.","family":"Alon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,19]]},"reference":[{"key":"3935_CR1","first-page":"231","volume-title":"Pediatric nephrology","author":"AA Portale","year":"2016","unstructured":"Portale AA, Perwad F (2016) Calcium and phosphorous. In: Avner E, Niaudet P, Emma F, Harmon WE, Yoshikawa N, Goldstein SL (eds) Pediatric nephrology, 7th edn. Springer, New York, pp 231\u2013266","edition":"7"},{"key":"3935_CR2","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/B978-1-4160-5583-9.00056-3","volume-title":"Endocrinology","author":"TJ Gardella","year":"2010","unstructured":"Gardella TJ, Juppner H, Brown EM, Kronenberg HM, Potts Jr JT (2010) Parathyroid hormone and parathyroid hormone-related peptide in the regulation of calcium homeostasis and bone development. In: DeGroot LJ, Jameson JL (eds) Endocrinology, 6th edn. W.B. Saunders, Philadelphia, pp 1040\u20131073","edition":"6"},{"key":"3935_CR3","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1038\/ki.1996.539","volume":"6","author":"SC Hebert","year":"1996","unstructured":"Hebert SC (1996) Extracellular calcium-sensing receptor: implications for calcium and magnesium handling in the kidney. Kidney Int 6:2129\u20132139","journal-title":"Kidney Int"},{"key":"3935_CR4","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/S0002-9343(98)00418-5","volume":"2","author":"EM Brown","year":"1999","unstructured":"Brown EM (1999) Physiology and pathophysiology of the extracellular calcium-sensing receptor. Am J Med 2:238\u2013253","journal-title":"Am J Med"},{"key":"3935_CR5","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1159\/000107069","volume":"5","author":"K Miyamoto","year":"2007","unstructured":"Miyamoto K, Ito M, Tatsumi S, Kuwahata M, Segawa H (2007) New aspect of renal phosphate reabsorption: the type IIc sodium-dependent phosphate transporter. Am J Nephrol 5:503\u2013515","journal-title":"Am J Nephrol"},{"key":"3935_CR6","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1152\/ajprenal.00608.2009","volume":"298","author":"R Daniela","year":"2010","unstructured":"Daniela R, Brown EM (2010) Physiology and pathophysiology of the calcium-sensing receptor in the kidney. Am J Physiol Ren Physiol 298:485\u2013499","journal-title":"Am J Physiol Ren Physiol"},{"key":"3935_CR7","first-page":"370","volume":"4","author":"CP McKay","year":"2008","unstructured":"McKay CP, Portale A (2008) Emerging topics in pediatric. Bone and mineral disorders. Semin Nephrol 4:370\u2013378","journal-title":"Semin Nephrol"},{"key":"3935_CR8","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0026-895X(24)13280-4","volume":"53","author":"LG Hammerland","year":"1998","unstructured":"Hammerland LG, Garrett JE, Hung BC, Levinthal C, Nemeth EF (1998) Allosteric activation of the Ca2+ receptor expressed in Xenopus laevis oocytes by NPS 467 or NPS 568. Mol Pharmacol 53:1083\u20131088","journal-title":"Mol Pharmacol"},{"key":"3935_CR9","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/nrneph.2016.59","volume":"12","author":"D Riccardi","year":"2016","unstructured":"Riccardi D, Valenti G (2016) Localization and function of the renal calcium-sensing receptor. Nat Rev Nephrol 12:414\u2013425","journal-title":"Nat Rev Nephrol"},{"key":"3935_CR10","doi-asserted-by":"publisher","first-page":"C221","DOI":"10.1152\/ajpcell.00139.2014","volume":"307","author":"TI Alfadda","year":"2014","unstructured":"Alfadda TI, Saleh AM, Houillier P, Geibel JP (2014) Calcium-sensing receptor 20 years later. Am J Physiol Cell Physiol 307:C221\u2013C231","journal-title":"Am J Physiol Cell Physiol"},{"key":"3935_CR11","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1152\/physrev.2001.81.1.239","volume":"81","author":"EM Brown","year":"2001","unstructured":"Brown EM, MacLeod RJ (2001) Extracellular calcium sensing and extracellular calcium signaling. Physiol Rev 81:239\u2013297","journal-title":"Physiol Rev"},{"key":"3935_CR12","doi-asserted-by":"publisher","unstructured":"Auron A, Alon US (2017) Hypercalcemia: a consultant\u2019s approach. Pediatr Nephrol. https:\/\/doi.org\/10.1007\/s00467-017-3788-z","DOI":"10.1007\/s00467-017-3788-z"},{"key":"3935_CR13","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1159\/000484064","volume":"43","author":"L Zhang","year":"2017","unstructured":"Zhang L, Ji T, Wang Q, Meng K, Zhang R, Yang H, Liao C, Ma L, Jiao J (2017) Calcium-sensing receptor stimulation in cultured glomerular podocytes induces TRPC6-dependent calcium entry and RhoA activation. Cell Physiol Biochem 43:1777\u20131789","journal-title":"Cell Physiol Biochem"},{"key":"3935_CR14","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/ki.2011.105","volume":"80","author":"J Oh","year":"2011","unstructured":"Oh J, Beckmann J, Bloch J, Hettgen V, Mueller J, Li L, Hoemme M, Gross ML, Penzel R, Mundel P, Schaefer F, Schmitt CP (2011) Stimulation of the calcium-sensing receptor stabilizes the podocyte cytoskeleton, improves cell survival, and reduces toxin-induced glomerulosclerosis. Kidney Int 80:483\u2013492","journal-title":"Kidney Int"},{"key":"3935_CR15","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1021\/ml5005365","volume":"6","author":"AF Abdel-Magid","year":"2015","unstructured":"Abdel-Magid AF (2015) Allosteric modulators: an emerging concept in drug discovery. ACS Med Chem Lett 6:104\u2013107","journal-title":"ACS Med Chem Lett"},{"key":"3935_CR16","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s00467-012-2381-8","volume":"28","author":"KJ Wesseling-Perry","year":"2013","unstructured":"Wesseling-Perry KJ, Salusky IB (2013) Phosphate binders, vitamin D and calcimimetics in the management of chronic kidney disease-mineral bone disorders (CKD-MBD) in children. Pediatr Nephrol 28:617\u2013625","journal-title":"Pediatr Nephrol"},{"key":"3935_CR17","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1007\/s00467-003-1290-2","volume":"18","author":"WG Goodman","year":"2003","unstructured":"Goodman WG (2003) Calcimimetic agents and secondary hyperparathyroidism: rationale for use and results from clinical trials. Pediatr Nephrol 18:1206\u20131210","journal-title":"Pediatr Nephrol"},{"key":"3935_CR18","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000401","volume":"94","author":"AA Alharthi","year":"2015","unstructured":"Alharthi AA, Naglaa MK, Abukhatwah WM, Sherief LM (2015) Cinacalcet in pediatric and adolescent chronic kidney disease: a single-center experience. Medicine 94:e401","journal-title":"Medicine"},{"key":"3935_CR19","doi-asserted-by":"crossref","unstructured":"Chonchol M, Locatelli F, Abboud HE, Charytan C, de Francisco ALM, Jolly S, Kaplan M, Roger SD, Sarkar S, Albizem MB, Mix TC, Kubo Y, Block GA (2009) A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet HCl in participants with CKD not receiving dialysis. Am J Kidney Dis 53:197\u2013207","DOI":"10.1053\/j.ajkd.2008.09.021"},{"issue":"9","key":"3935_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0161527","volume":"11","author":"A P\u00e9rez-Ricart","year":"2016","unstructured":"P\u00e9rez-Ricart A, Galicia-Basart M, Alcalde-Rodrigo M, Segarra-Medrano A, Su\u00f1\u00e9-Negre JM, Montoro-Ronsano JB (2016) Effectiveness of cinacalcet in patients with chronic kidney disease and secondary hyperparathyroidism not receiving dialysis. PLoS One 11(9):e0161527","journal-title":"PLoS One"},{"key":"3935_CR21","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1111\/cen.13453","volume":"87","author":"W Wang","year":"2017","unstructured":"Wang W, Konk J, Nie M, Jiang Y, Me L (2017) Primary hyperparathyroidism in Chinese children and adolescents: a single-center experience at Peking Union Medical College Hospital. Clin Endocrinol 87:865\u2013873","journal-title":"Clin Endocrinol"},{"key":"3935_CR22","doi-asserted-by":"publisher","first-page":"5644","DOI":"10.1210\/jc.2002-021597","volume":"88","author":"DM Shoback","year":"2003","unstructured":"Shoback DM, Bilezikian JP, Turner SA, McCary LC, Guo MD, Peacock M (2003) The calcimimetic cinacalcet normalizes serum calcium in subjects with primary hyperparathyroidism. J Clin Endocinol Metab 88:5644\u20135649","journal-title":"J Clin Endocinol Metab"},{"key":"3935_CR23","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1210\/jc.2004-0842","volume":"90","author":"M Peacock","year":"2005","unstructured":"Peacock M, Bilezikian JP, Klassen PS, Gou MD, Turner SA, Shoback D (2005) Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism. J Clin Endocrinol Metab 90:135\u2013141","journal-title":"J Clin Endocrinol Metab"},{"key":"3935_CR24","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/jso.20182","volume":"89","author":"EA Mittendorf","year":"2005","unstructured":"Mittendorf EA, McHenry CR (2005) Parathyroid carcinoma. J Surg Oncol 89:136\u2013142","journal-title":"J Surg Oncol"},{"key":"3935_CR25","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1053\/j.ajkd.2006.07.019","volume":"48","author":"JA Sloand","year":"2006","unstructured":"Sloand JA, Shelly MA (2006) Normalization of lithium-induced hypercalcemia and hyperparathyroidism with cinacalcet hydrochloride. Am J Kidney Dis 48:832\u2013837","journal-title":"Am J Kidney Dis"},{"key":"3935_CR26","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/0092-8674(93)90617-Y","volume":"75","author":"MR Pollak","year":"1993","unstructured":"Pollak MR, Brown EM, Chou YH, Herbert SC, Marx SJ, Steinmann B, Levi T, Seidman CE, Seidman JG (1993) Mutation in the human Ca2+-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 75:1297\u20131303","journal-title":"Cell"},{"key":"3935_CR27","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1365-2265.2007.03027.x","volume":"68","author":"B Festen-Spanjer","year":"2007","unstructured":"Festen-Spanjer B, Haring CM, Koster JB, Mudde AH (2007) Correction of hypercalcaemia by cinacalcet in familial hypocalciuric hypercalcaemia. Clin Endocrinol 68:324\u2013325","journal-title":"Clin Endocrinol"},{"key":"3935_CR28","doi-asserted-by":"publisher","first-page":"362","DOI":"10.4103\/2230-8210.202034","volume":"21","author":"BK Sethi","year":"2017","unstructured":"Sethi BK, Nagesh VS, Kelwade J, Parekh H, Dukle V (2017) Utility of cinacalcet in familial hypocalciuric hypercalcemia. Indian J Endocrinol Metab 21:362\u2013363","journal-title":"Indian J Endocrinol Metab"},{"key":"3935_CR29","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1007\/s00467-010-1547-5","volume":"25","author":"US Alon","year":"2010","unstructured":"Alon US, VanDeVoorde RG (2010) Beneficial effect of cinacalcet in a child with familial hypocalciuric hypercalcemia. Pediatr Nephrol 25:1747\u20131750","journal-title":"Pediatr Nephrol"},{"key":"3935_CR30","doi-asserted-by":"publisher","first-page":"566","DOI":"10.2174\/156652412800619969","volume":"12","author":"B Izzi","year":"2012","unstructured":"Izzi B, Van Geet C, Freson K (2012) Recent advances in GNAS epigenetic research of pseudohypoparathyroidism. Curr Mol Med 12:566\u2013573","journal-title":"Curr Mol Med"},{"key":"3935_CR31","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1359\/jbmr.1999.14.6.1016","volume":"14","author":"Z Farfel","year":"1999","unstructured":"Farfel Z (1999) Pseudohypohyperparathyroidism-pseudohypoparathyroidism type Ib. J Bone Miner Res 14:1016","journal-title":"J Bone Miner Res"},{"key":"3935_CR32","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s00467-015-3271-7","volume":"31","author":"T Srivastava","year":"2016","unstructured":"Srivastava T, Krudys J, Mardis NJ, Sebestyen-VanSickle J, Alon US (2016) Cinacalcet as adjunctive therapy in pseudohypoparathyroidism type 1b. Pediatr Nephrol 31:795\u2013800","journal-title":"Pediatr Nephrol"},{"key":"3935_CR33","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/s00774-009-0079-1","volume":"27","author":"D Tiosano","year":"2009","unstructured":"Tiosano D, Hochberg Z (2009) Hypophosphatemia: the common denominator of all rickets. J Bone Miner Metab 27:392\u2013401","journal-title":"J Bone Miner Metab"},{"key":"3935_CR34","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.ecl.2010.02.004","volume":"39","author":"PJ Malloy","year":"2010","unstructured":"Malloy PJ, Feldman D (2010) Genetic disorders and defects in vitamin D action. Endocrinol Metab Clin N Am 39:333\u2013346","journal-title":"Endocrinol Metab Clin N Am"},{"key":"3935_CR35","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/0002-9343(87)90666-8","volume":"83","author":"Y Weisman","year":"1987","unstructured":"Weisman Y, Bab I, Gazit D, Spirer Z, Jaffe M, Hochberg Z (1987) Long-term intracaval calcium infusion therapy in end-organ resistance to 1,25-dihydroxyvitamin D. Am J Med 83:984\u2013990","journal-title":"Am J Med"},{"key":"3935_CR36","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1002\/jbmr.1838","volume":"28","author":"T Srivastava","year":"2013","unstructured":"Srivastava T, Alon US (2013) Cinacalcet as adjunctive therapy for hereditary 1,25-dihydroxyvitamin D-resistant rickets. J Bone Miner Res 28:992\u2013996","journal-title":"J Bone Miner Res"},{"key":"3935_CR37","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1002\/jbmr.340","volume":"26","author":"TO Carpenter","year":"2011","unstructured":"Carpenter TO, Imel EA, Holm IA, Jan de Beur SM, Insogna KL (2011) A clinician\u2019s guide to X-linked hypophosphatemia. J Bone Miner Metab 26:1381\u20131388","journal-title":"J Bone Miner Metab"},{"key":"3935_CR38","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s00467-013-2466-z","volume":"29","author":"M Penido","year":"2014","unstructured":"Penido M, Alon US (2014) Hypophosphatemic rickets due to perturbations in renal tubular function. Pediatr Nephrol 29:361\u2013373","journal-title":"Pediatr Nephrol"},{"key":"3935_CR39","doi-asserted-by":"crossref","unstructured":"Alon US (2011) Fibroblast growth factor (FGF)-23: a new hormone. European J Pediatr 170:545\u2013554","DOI":"10.1007\/s00431-010-1382-5"},{"key":"3935_CR40","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/S0022-3476(81)80951-1","volume":"99","author":"H Rasmussen","year":"1981","unstructured":"Rasmussen H, Pechet M, Anast C, Mazur A, Gertner J, Broadus AE (1981) Long-term treatment of familial hypophosphatemic rickets with oral phosphate and 1 \u03b1-hydroxyvitaminD3. J Peidatr 99:16\u201325","journal-title":"J Peidatr"},{"key":"3935_CR41","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1172\/JCI111900","volume":"75","author":"RM Harrell","year":"1985","unstructured":"Harrell RM, Lyles KW, Harrelson JM, Friedman NE, Drezner MK (1985) Healing of bone disease in X-linked hypophosphatemic rickets\/osteomalacia. J Clin Invest 75:1858\u20131868","journal-title":"J Clin Invest"},{"key":"3935_CR42","doi-asserted-by":"publisher","first-page":"S101","DOI":"10.1530\/EJE-08-0383","volume":"159","author":"H Raeder","year":"2008","unstructured":"Raeder H, Shaw N, Netelenbos C, Bjerknes R (2008) A case of X-linked hypophosphatemic rickets: complications and the therapeutic use of cinacalcet. Euro J Endocrinol 159:S101\u2013S105","journal-title":"Euro J Endocrinol"},{"key":"3935_CR43","doi-asserted-by":"publisher","first-page":"274","DOI":"10.14310\/horm.2002.1277","volume":"9","author":"MP Yavropoulo","year":"2010","unstructured":"Yavropoulo MP, Kosta K, Gotzamani Psarrakou A, Papazisi A, Tranga T, Ventis S, Yovos JG (2010) Cinacalcet in hyperparathyroidism secondary to X-linked hypophosphatemic rickets: case report and brief literature review. Hormones 9:274\u2013278","journal-title":"Hormones"},{"key":"3935_CR44","doi-asserted-by":"publisher","first-page":"658","DOI":"10.2215\/CJN.04981107","volume":"3","author":"US Alon","year":"2008","unstructured":"Alon US, Levy-Olomucki L, Wayne V, Moore JS, Liu S, Quarles DL (2008) Calcimimetics as an adjuvant treatment for familial Hypophosphatemic rickets. Clin J Am Soc Nephro 3:658\u2013664","journal-title":"Clin J Am Soc Nephro"},{"key":"3935_CR45","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1210\/jcem-58-4-671","volume":"58","author":"US Alon","year":"1984","unstructured":"Alon US, Chan JCM (1984) Effects of PTH and 1,25 dihydroxyvitamin D3 on tubular handling of phosphate in hypophosphatemic rickets. J Clin Endocrinol Metab 58:671\u2013675","journal-title":"J Clin Endocrinol Metab"},{"key":"3935_CR46","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/cen.13346","volume":"87","author":"US Alon","year":"2017","unstructured":"Alon US, Jarka D, Monachino PJ, Sebestyen VanSickle J, Srivastava T (2017) Cinacalcet as an alternative to phosphate therapy in X-linked hypophosphatemic rickets. Clin Endocrinol 87:114\u2013116","journal-title":"Clin Endocrinol"},{"key":"3935_CR47","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1542\/peds.70.3.360","volume":"70","author":"KG Hufnagle","year":"1982","unstructured":"Hufnagle KG, Khan SN, Penn D, Cacciarelli A, Williams P (1982) Renal calcification: a complication of long-term furosemide in preterm infants. Pediatrics 70:360\u2013363","journal-title":"Pediatrics"},{"key":"3935_CR48","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1007\/s004310051173","volume":"158","author":"T Saarela","year":"1999","unstructured":"Saarela T, Lanning P, Koivisto M, Paavilainen T (1999) Nephrocalcinosis in full-term infants receiving furosemide treatment for congestive heart failure: a study of the incidence and 2-year follow up. Eur J Pediatr 158:668\u2013672","journal-title":"Eur J Pediatr"},{"key":"3935_CR49","first-page":"1157","volume":"137","author":"PS Venkataraman","year":"1983","unstructured":"Venkataraman PS, Han BF, Tsang RC, Daugherty CC (1983) Secondary hyperparathyroidism and bone disease in infants receiving long-term furosemide therapy. Am J Dis Child 137:1157\u20131161","journal-title":"Am J Dis Child"},{"key":"3935_CR50","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1001\/jamainternmed.2014.5857","volume":"175","author":"K Corapi","year":"2015","unstructured":"Corapi K, McMahon GM, Wenger J, Seifter J, Bhan I (2015) Association of loop diuretic use with higher parathyroid hormone levels in patients with normal renal function. JAMA Intern Med 175:137\u2013138","journal-title":"JAMA Intern Med"},{"key":"3935_CR51","doi-asserted-by":"crossref","unstructured":"Coe FL, Canterbury JM, Firpo JJ, Reiss E (1973) Evidence for secondary hyperparathyroidism in idiopathic hypercalciuria. J Clin Invest:134\u2013142","DOI":"10.1172\/JCI107156"},{"key":"3935_CR52","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1159\/000183610","volume":"41","author":"T Fujita","year":"1985","unstructured":"Fujita T, Delea CS, Bartter FC (1985) The effects of oral furosemide on the response of urinary excretion of cyclic adenosine monophosphate and phosphate to parathyroid extract in normal subjects. Nephron 41:333\u2013336","journal-title":"Nephron"},{"key":"3935_CR53","first-page":"357A","volume":"39","author":"US Alon","year":"1996","unstructured":"Alon US, Nichols MA, Alon MM (1996) Critical role of parathyroid hormone in furosemide-induced nephrocalcinosis in the young rat. Pediatr Res 39:357A","journal-title":"Pediatr Res"},{"key":"3935_CR54","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1111\/j.1523-1755.2004.00564.x","volume":"65","author":"A Pattaragarn","year":"2004","unstructured":"Pattaragarn A, Fox J, Alon US (2004) Effect of the calcimimetic NPS R-467 on furosemide-induced nephrocalcinosis in the young rat. Kidney Int 65:1684\u20131689","journal-title":"Kidney Int"},{"key":"3935_CR55","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-3789","volume":"140","author":"T Srivastava","year":"2017","unstructured":"Srivastava T, Jafri S, Truog W, Sebestyen VanSickle J, Maimtim W, Alon US (2017) Successful reversal of furosemide-induced secondary hyperparathyroidism with cinacalcet. Pediatrics 140:e20163781","journal-title":"Pediatrics"},{"key":"3935_CR56","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/S0022-3476(83)80253-4","volume":"102","author":"ZD Najak","year":"1983","unstructured":"Najak ZD, Harris EM, Jr LA, Pruitt AW (1983) Pulmonary effects of furosemide in preterm infants with lung disease. J Pediatr 102:758\u2013763","journal-title":"J Pediatr"},{"key":"3935_CR57","doi-asserted-by":"crossref","unstructured":"Muller ME, Forni-Ogna V, Maillard M, Stoudmann C, Zweiacker C, Anex C, Wuerzner G, Burnier M, Bonny O (2015) Furosemide stimulation of parathormone in humans: role of the calcium-sensing receptor and the renin-angiotensin system. Pflugers Arch 467:2413\u20132421","DOI":"10.1007\/s00424-015-1714-4"},{"key":"3935_CR58","doi-asserted-by":"crossref","unstructured":"Srivastava T, Alon US (2007) Pathophysiology of hypercalciuria in children. Pediatr Nephrol (10):1659\u20131673","DOI":"10.1007\/s00467-007-0482-6"},{"key":"3935_CR59","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1210\/jcem-57-5-920","volume":"57","author":"D Leppla","year":"1983","unstructured":"Leppla D, Browne R, Hill K, Pak CY (1983) Effect of amiloride with or without hydrochlorothiazide on urinary calcium and saturation of calcium salts. J Clin Endocrinol Metab 57:920\u2013924","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-018-3935-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-018-3935-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-018-3935-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T21:30:19Z","timestamp":1751491819000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-018-3935-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,19]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["3935"],"URL":"https:\/\/doi.org\/10.1007\/s00467-018-3935-1","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"type":"print","value":"0931-041X"},{"type":"electronic","value":"1432-198X"}],"subject":[],"published":{"date-parts":[[2018,3,19]]},"assertion":[{"value":"30 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}